Загрузка...
Rationale for STING-targeted cancer immunotherapy
The efficacy of checkpoint inhibitor therapy illustrates that cancer immunotherapy, which aims to foster the host immune response against cancer to achieve durable anticancer responses, can be successfully implemented in a routine clinical practice. However, a substantial proportion of patients does...
Сохранить в:
| Опубликовано в: : | Eur J Cancer |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362072/ https://ncbi.nlm.nih.gov/pubmed/28219022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.12.028 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|